TBC1D3F

Chr 17

TBC1 domain family member 3F

Predicted to enable GTPase activator activity. Predicted to be located in endosome and plasma membrane. [provided by Alliance of Genome Resources, Jun 2026]

OMIMResearchGenerating clinical summary…
0
Active trials
0
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.95
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.95LOEUF
pLI 0.000
Z-score -1.22
OE 1.70 (0.82–1.95)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.06Z-score
OE missense 1.03 (0.79–1.35)
37 obs / 36.0 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?1.70 (0.82–1.95)
0≤0.351.4
Missense OE?1.03 (0.79–1.35)
0≤0.61.4
Synonymous OE?0.87
0≤1.21.6
LoF obs/exp: 6 / 3.5Missense obs/exp: 37 / 36.0Syn Z: 0.38

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

TBC1D3F · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →